Description: Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Home Page: www.embecta.com
300 Kimball Drive
Parsippany,
NJ
07054
United States
Phone:
862 401 0000
Officers
| Name | Title |
|---|---|
| Mr. Devdatt Kurdikar | President, CEO & Director |
| Mr. Jacob P. Elguicze | Senior VP & CFO |
| Mr. Jeffrey Z. Mann | Senior VP, General Counsel, Head of Business Development & Corporate Secretary |
| Mr. Shaun Curtis | Senior Vice President of Global Manufacturing & Supply Chain |
| Ms. Colleen Riley | Senior VP & Chief Technology Officer |
| Mr. Pravesh Khandelwal | VP & Head of Investor Relations |
| Ms. Ginny Blocki | Senior Vice President of Global Marketing & Product Management |
| Ms. Jean M. Casner | Senior VP & Chief Human Resources Officer |
| Mr. Tom Blount | Senior VP & President of North America |
| Mr. Slobodan Radumilo | Senior VP & President of International |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 14.4882 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.9744 |
| IPO Date: | |
| Fiscal Year End: | September |
| Full Time Employees: | 2200 |